# Smectic Superconductivity

Preprint · Grayson R. Frazier, Erez Berg

- Archive id: arxiv:2609.20932
- Published: 2026-09-17
- arXiv: https://arxiv.org/abs/2609.20932
- Source URL: https://arxiv.org/abs/2609.20932
- PDF: https://arxiv.org/pdf/2609.20932
- Provenance: arxiv

## Abstract

We identify a mechanism in which soft nonunitary fluctuations of the pair condensate can suppress phase coherence in a two-dimensional Rashba superconductor proximate to easy-plane ferromagnetic order. This spin polarization couples linearly to the supercurrent through a Lifshitz invariant, acting as an emergent gauge field for the superconducting $\\mathrm{U}(1)$ phase. Integrating out soft magnetic fluctuations renormalizes the effective superfluid stiffness and drives the system into a "smectic" superconducting state, characterized by a finite-momentum helical phase texture and a long-wavelength stiffness that vanishes in one direction. Consequently, vortices no longer have a logarithmically divergent energy cost, and the quasi-long-range superconducting order is destroyed at any finite temperature. Weak lattice anisotropy pins the ferromagnetic order, cutting off the smectic-like behaviour at long wavelengths and thereby restoring a finite effective stiffness. Nonetheless, near the onset of magnetic order, the enhanced magnetic susceptibility leads to a vortex-deconfined regime for arbitrarily weak magnetoelectric coupling. The results provide insight into how intertwined superconducting and easy-plane ferromagnetic orders can reshape phase coherence, with relevance to rhombohedral graphene proximitized by a transition-metal dichalcogenide substrate.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Moire & 2D Superconductivity](https://space-kitty.com/topics/moire-superconductivity)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.